DarioHealth logo

DarioHealth (DRIO) Q1 2026 Earnings

DRIO·Reported May 13, 2026·Before market open

DarioHealth reported Q1 2026 revenue of $5.6M (-17.3% YoY), beat analyst consensus of $5.5M by $128.0K. Diluted EPS came in at $-0.81 (+32.5% YoY), beat the $-1.48 consensus by $0.67.

Revenue
$5.6Mbeat by $128.0K
Consensus: $5.5M
Diluted EPS
$-0.81beat by $0.67
Consensus: $-1.48
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q · 0001104659-26-059676

Financial Snapshot

Trailing eight quarters through Q1 2026

View all metrics

Q1 2026 Earnings FAQ

Common questions about DarioHealth's Q1 2026 earnings report.

DarioHealth (DRIO) reported Q1 2026 earnings on May 13, 2026 before market open.

DarioHealth reported revenue of $5.6M and diluted EPS of $-0.81 for Q1 2026.

Revenue beat the consensus estimate of $5.5M by $128.0K. EPS beat the consensus estimate of $-1.48 by $0.67.

Compared to the same quarter a year prior, revenue declined 17.3% from $6.8M a year earlier and diluted EPS grew 32.5% from $-1.20.

You can read the 10-Q periodic report (0001104659-26-059676) directly on SEC EDGAR. The filing index links above go to sec.gov.